Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...

Gene sequencing studies have uncovered mutations in key oncogenes responsible for colorectal cancer (CRC) development. CRC ...

A recent high-throughput study shows that some types of cancer are associated with mutations in a specific proto-oncogene or in a specific pair of proto-oncogenes (Thomas et al., 2007).

Researchers from Fujita Health University, Japan, uncover specific gene mutations and mechanisms that may contribute to the ...

For instance, one 2016 study reported that a handful of synonymous mutations in the KRAS oncogene changed a rare glycine-encoding codon into a commonly used one, potentially accelerating translation.

Researchers used mutational analysis to identify gene mutations that may drive carcinogenesis in colorectal tumors with high ...

tumor cells produce chemical growth factors by switching on oncogenes. Many tumors rely on a mutation of the RAS oncogene in order to develop. Scientists hope that new anti-oncogenic drugs ...

Webcasts will be available at the start of the presentations on the investor relations section of the Company’s website, www.blackdiamondtherapeutics.com. Replays of the presentations will also be ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer-related deaths worldwide.

tumors with high tumor mutation burden that lack mutations in the major oncogenes. Their findings highlight alternate site-specific mechanisms of CRC development that can guide treatment selection ...